Join Philip Blum, MD, for a free, previously recorded webinar on the latest treatment advances for Alzheimer’s disease.
Affiliated with Memorial Hermann Mischer Neurosciences and part of Mischer Neuroscience Associates, Dr. Blum has special training in immunology and the impact of immunological disease and treatment on the nervous system, including Alzheimer’s disease.
Dr. Blum will discuss the newest Alzheimer’s disease drug, lecanemab.
During the webinar, you will learn more about:
Para comunicarse con Memorial Hermann, complete el formulario a continuación.